News

Dave Inc. Reports Stellar Growth in 2024 Financials

Dave Inc. Reports Stellar Growth in 2024 Financials

Dave Inc. Achieves Remarkable Growth in Q4 and Full Year 2024

Dave Inc. (NASDAQ: DAVE), a prominent neobank and fintech company, has announced stellar financial results for the fourth quarter and the entire year ending December 31, 2024. The company reported an impressive increase in both revenue and net income, marking a substantial leap compared to previous years.

Record Revenue and Income Figures

The fourth quarter revenues surged by an impressive 38% year-over-year, reaching $100.9 million, while the full year revenue grew by 34% to a total of $347.1 million. These results epitomize the company’s dedication to growth and profitability in a fast-evolving neobanking sector.

Net Income Growth

In terms of profitability, Dave achieved a remarkable net income of $16.8 million for Q4, which represents an increase of $16.6 million from the previous year. Adjusted EBITDA skyrocketed by 234%, amounting to $33.4 million and significantly exceeding the upper limits of company guidance. This robust performance underlines the operational efficiencies and strong member engagement that are driving the company forward.

Strategic Roadmap for 2025

Looking ahead, Dave has established a solid outlook for 2025. With strong momentum, the company aims to implement a new fee structure resulting in enhanced ExtraCash limits for its users. The ongoing commitment to innovation is expected to further elevate member value through improved monetization strategies.

Growing Membership and Customer Engagement

In Q4 2024, Dave witnessed a 12% increase in new members, with the total rising to 766,000. Additionally, the Monthly Transacting Members (MTMs) grew by 17%, reaching 2.5 million. This growth was supported by highly efficient customer acquisition costs, averaging just $16.

Financial Highlights from 2024

Here are some key financial highlights from the past year:

  • Q4 Net Income: $16.8 million
  • Full Year Revenue: $347.1 million (up 34% YoY)
  • Adjusted EBITDA: $33.4 million (up 234% YoY)
  • New Membership Growth: 12%, totaling 766,000 members
  • Cash Flow Increase: $91.9 million in cash and cash equivalents by the end of the year

Commitment to Sustainable Growth

CFO Kyle Beilman emphasized that the financial guidance for 2025 reflects the advantages created by the new fee structure, coupled with a strong focus on sustainable and profitable growth. Expectations are set for an increase in Average Revenue Per User (ARPU) alongside ongoing efforts to bolster member retention and extend lifetime value.

Partnership for Enhanced Banking Services

The recent strategic partnership with Coastal Community Bank aims to enhance banking services for Dave’s members and promote financial inclusion among everyday Americans. This alignment underscores Dave’s commitment to innovation and customer-centric services.

Looking Ahead: Questions and Commentary

As Dave continues to grow and refine its offerings, the company will hold a conference call to discuss these financial results and future direction. Investors and analysts are encouraged to follow updates as the company embarks on this promising trajectory.

Frequently Asked Questions

What were Dave Inc.'s revenues for Q4 and FY 2024?

Dave Inc. reported revenues of $100.9 million for Q4 and $347.1 million for the full year 2024.

How did Dave's net income change in Q4 2024?

Net income increased to $16.8 million, up $16.6 million from the prior year.

What is the company's EBITDA for Q4 2024?

Adjusted EBITDA reached $33.4 million, reflecting a 234% year-over-year increase.

How many new members did Dave acquire in 2024?

The company acquired 766,000 new members, representing a 12% growth.

What is the strategic focus for Dave in 2025?

Dave is focusing on enhancing its fee structure, increasing member lifetime value, and expanding new banking partnerships.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 3

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 0

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 4

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 0

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 1

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading

Top 5 Most Recently Viewed Articles

Jazz Pharmaceuticals Releases Promising Long-Term Ziihera Data

Updated Category News Views 148

Jazz Pharmaceuticals Announces Encouraging Ziihera Results Jazz Pharmaceuticals plc (NASDAQ: JAZZ) recently revealed significant data from their Phase 2 trial concerning Ziihera (zanidatamab-hrii). This research focuses on individuals battling HER2-positive metastatic gastroesophageal adenocarcinoma (mGEA) and has showcased a substantial long-term median overall survival...

Continue Reading
Dräger Achieves Perfect CMMC Level 2 Certification Success

Updated Category News Views 271

Dräger's Commitment to Cybersecurity Excellence In today’s digital age, ensuring the highest level of data security is crucial for organizations involved in medical and safety technologies. Recently, Dräger, a well-respected name in healthcare technology, accomplished a significant milestone by obtaining Cybersecurity Maturity Model Certification (CMMC) Level 2,...

Continue Reading
Nykredit Realkredit A/S Announces Key Coupon Rate Changes

Updated Category News Views 220

Understanding the Recent Coupon Rate Adjustments The financial market often sees adjustments in coupon rates, a critical element for investors. Nykredit Realkredit A/S, a notable player in the bond market, has announced modifications that will be effective from a future date. These changes will directly impact the floating-rate bonds issued by the company. Effective Date...

Continue Reading
Transformative IT Strategies for CIOs: Insights for 2025

Updated Category News Views 162

Shift from Disruption to Proactive Strategies for CIOs As 2025 unfolds, recent insights from Info-Tech Research Group reveal a transformative movement among IT leaders. These leaders are transitioning from mere reactive responses to disruptive challenges, embracing proactive strategies focused on artificial intelligence, cybersecurity, infrastructure development, and...

Continue Reading
Immix Biopharma to Showcase Innovative NXC-201 Research Soon

Updated Category News Views 104

Immix Biopharma to Present NXC-201 at Prominent Annual Meeting Immix Biopharma, Inc. (NASDAQ: IMMX), a leader in developing therapies for relapsed/refractory AL Amyloidosis, is excited to announce its upcoming presentation at a major annual meeting organized by the American Society of Hematology (ASH). The event will showcase the promising NXC-201 therapy, which focuses...

Continue Reading